14-Sep-2020 | Market Research Store
New research has shown the use of rheumatoid arthritis (RA) drugs to help treat the preliminary stages of heart disease. However, there is a known fact that rheumatoid arthritis increases the chances of developing cardiovascular disease (CVD) which is currently one of the leading causes of death or disability across the globe. In the case of heart diseases, atherosclerosis is known to usually occur wherein there is accumulation of plaque inside the arteries and this ultimately leads to strokes and heart failure. Researchers from the University of Leeds have for the first-ever time found rheumatoid arthritis drugs to help lower vascular stiffness, which is the first sign of CVD.
The RA sufferers who have developed the condition are likely to have the condition cured within a few months. The researchers have been able to provide through their findings that the drugs used to treat the earliest stages of rheumatoid arthritis lower heart abnormalities such as the vascular stiffness of the aorta. This new finding was an unexpected outcome that is likely to be paid more attention as the RA treatment changes the metabolic profile and direct effect on the processes of heart and vascular disease. Rheumatoid is a disease that is incurable that could be diagnosed early and treated using disease-modifying antirheumatic drugs (DMARDs) to help control the condition which usually affects women, smokers, and it also hereditary.
Additionally, the inflammation of rheumatoid arthritis is also increase the risks of CVD coupled with the increase in the lipid and glucose metabolism. Although the benefits of rheumatoid arthritis have been backed there are concerns that if the therapy is reduced there are chances that risk of CVD progression increases. The focus over tailoring the therapies related to rheumatoid arthritis and associated CVD still needs to be scrutinized for advancing its further use in modern medicine.
Market Research Store has published a report on global rheumatoid arthritis therapeutics market. This report on rheumatoid arthritis therapeutics market clarifies the market size, share, revenue, supply & demand chain, growth rate, and foreseeable trends in an elaborative and figurative context.